Paclitaxel Albumin Encapsulated – Available as Lyophilized powder/100mg vials & Nano Particles (Patent Non infringing)
Paclitaxel Nano-Pellets for Injection. Paclitaxel is a mitotic inhibitor drip used in the treatment of cancer.
- MKPPL is the only the sixth company in India to have developed successfully nab-paclitaxel, the other companies being Cipla, Sun Pharma, Cadila-Zydus, Intas and Natco.
- The particle size and the encapsulation efficiency have matched the innovator’s specifications.
- In vitro cell line studies have shown that the activity is comparable to the innovator.
- Offer complete technical package for registrations in all regulated/semi regulated markets.
Share
Additional information
| Percentage | 0.5%, 1%, 5% |
|---|---|
| Mesh Size | 100 micron used in injection |
| Routes of administration | Intravenous |
| Target Formulations | Injectables |
| Documentation Available: | Technical Package |
Description
Paclitaxel is now used to treat patients with lung, ovarian, breast cancer, head and neck cancer, and advanced forms of Kaposi’s sarcoma. Paclitaxel is also used for the prevention of restenosis.
Paclitaxel stabilizes microtubules and as a result, interferes with the normal breakdown of microtubules during cell division.
